Neuropati Optik Traumatik: Gambaran 13 Kasus Berdasarkan Radiologi dan Awitan Terapi Kortikosteroid di Rumah Sakit Cipto Mangunkusumo
Article Sidebar
-
Traumatic Optic Neuropathy, Corticosteroid therapy, Radiology Feature
Abstract
Introduction and Objection: Traumatic Optic Neuropathy is a rare and potentially vision-threatening condition caused by ocular or head trauma. The optic nerve axons may be damaged either directly or indirectly. The management of traumatic optic neuropathy could be observed, giving steroids or decompression. At center which optic nerve decompression is not routinely performed, high dose steroid is preferred for traumatic optic neuropathy patients. The study aims to analyze characteristics (mean age and gender, onset trauma, most symptom, visual acuity, consensual reflex as a sign), radiology feature, and onset corticosteroid therapy on patient traumatic optic neuropathy.
Methods: This study was a descriptive observational case series which data retrospectively analysis from medical record.
Result: From 13 cases most common gender affected were males (76,9%). The mean age group 32.85±14.67 years old with blurry vision and bleeding are the most common symptom, the onset of trauma below 24 hours (76.9%), the initial visual acuity is no light perception and hand movement with a negative consensual reflex (76.9%). Visual acuity improves with initial corticosteroid therapy below 24 hours are 7 cases and more than 24 hours are 2 cases. From 9 cases with visual acuity improvement, there are 4 cases with orbital fracture and 5 cases without orbital fracture.
Conclusion: Visual improvement in our cases happened more on initial corticosteroid therapy more than 24 hours and no orbital fracture.
Full text article
References
Yu B, Ma YJ, Tu YH, Wu WC. Newly onset indirect traumatic optic neuropathy-surgical treatment first versus steroid treatment first. Int Journal Ophthalmol. 2020;13(1):124-128.
Samardzic K, Samardzic J, Janjetovic Z, Samardzic I, Sekelj S, Hodzic LL. Traumatic Optic Neuropathy-To Treat or To Observe?. Acta Inform Med. 2012;20(2):131-132.
Foroozan RF, Bhatti MT, Falardeau J, Gordon LKG, Lee MS, Subramanian PS, et al. Traumatic Optic Neuropathy. In: Cantor LB, Rapuano CJ, Cioffi GA, editors. Basic Clinical Science and Course. Neuroophthalmology. 5. San Fransisco: American Academy of Ophthalmology; 2014. p. 143-4.
Steinsapir KD, Goldberg RA. Traumatic optic neuropathy: an evolving understanding. Am J Ophthalmol. 2011;151(6):928-33. e2.
Singman EL, Daphalapurkar N, White H, Nguyen TD, Panghat L, Chang J, et al. Indirect traumatic optic neuropathy. MMR. 2016;3(1):1-6.
Wu N, Yin ZQ, Wang Y. Traumatic Optic Neuropathy Therapy: an Update of Clinical and Experimental Studies. J Int Med Res. 2008; 36: 883 – 9.
Yu WMP, Griffiths PG. Steroids for traumatic optic neuropathy.Cochrane Database Syst Rev. 2013; 6: 1-21.
Mahayani NMW, Triningrat AAMP, Manuaba IBP. Karakteristik Pasien Traumatik Optik Neuropati (TON) yang mendapat terapi Kortikosteroid dosis tinggi dibandingkan dengan Observasi di RSUP Sanglah Denpasar Tahun 2013-2015. Med. 2017;48(3):201-205.
Daniel H, Nusanti S, Sidik M. Karakteristik, Hasil Terapi dan Prediktor keberhasilan Terapi Pasien Neuropati Optik Traumatik (NOT) Divisi Neurooftalmologi Rumah Sakit Cipto Mangunkusumo. Ophthalmol Ina. 2018;44(1):17-23.
Huang TL, Chen N, Lin KH, Tsai RK. Current treatment of traumatic optic neuropathy. Neuro-Ophthalmology Japan. 2014; 31(2): 259-262.
Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R, Group IONTS. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmol. 1999;106(7):1268-77.
Bonapally UK, dkk. Traumatic Optic Neuropathy Pediction after Blunt Facial Trauma: Derivation of a Risk Score Based on Facial CT Findings at Admission. Radiol. 2014;272(3):824-830.
Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, dkk. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. N Eng J Med. 1990;322(20):1405-11.
Bracken MB, Sperad MJ,Holford TR, dkk. Administration of methylprednisolone for 24 or 48 hours or trilazard mesylate for 48 hour in the treatment of acute spinal cord injury. Result of the Third National Acute Spinl Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277:1597-604.
Das H, Badhu BP, Gautam MA. Indirect traumatic Optic Neuropathy-Restropective Interventional Case Series from a tertiary Care Center in Eastern Nepal. JNMA. 2007;46(2):57-61.
Hsieh C-H, Kuo Y-R, Hung H-C, Tsai H- H, Jeng S-F. Indirect traumatic optic neuropathy complicated with periorbital facial bone fracture. J Trauma Acute Care Surg. 2004;56(4):795-801.
Tsai H-H, Jeng S-F, Lin T-S, Kueh N-S, Hsieh C-H. Predictive value of computed tomography in visual outcome in indirect traumatic optic neuropathy complicated with periorbital facial bone fracture. Clin Neurol Neurosurg. 2005;107(3):200-6.
Reddy RP, Bodanapally UK, Shanmuganathan K, Van der Byl G, Dreizin D, Katzman L, et al. Traumatic optic neuropathy: facial CT findings affecting visual acuity. Emerg Radiol. 2015;22(4):351-6.
Lee KF, Nor IM, Yaakub A, Hitam WHW. Traumatic optic neuropathy: a review of 24 patients. Int J Ophthalmol. 2010;3(2):175-178.
Sadeghi-Tari A, Lashay AR, Tabassi A. Visual Outcome of traumatic optic neuropathy in patients treated with intravenous megadose of steroids. Acta Med Iran. 2005;43(2):110-114.
Rampriya C, Visalakshi S, Sudha N. A Case series on Traumatic Optic Neuropathy. IOSR- JDMS. 2019:18(5):43-47.
Saxena R, Singh D, menon V. Controversies in neuro-ophthalmology: Steroid theraphy for the Traumatic Optic Neuropathy. Indian J Ophthalmol. 2014;62:1028-30.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.